ATLAS fair value
$123.59
Above fair value · 38% premium
Balchem stock price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · NASDAQ
Prices as of Oct 26, 2026 · USD
$123.59
Above fair value · 38% premium
54%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Balchem's fair value at about $123.59 per share (reasonable range: $89.13 to $171.36). At $170.62, the stock trades 38% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Balchem a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $166.03 and $176.90; in 9 out of 10, between $156.95 and $187.13. Estimated annual volatility is 16%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Balchem sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks BCPC has traded between $147.18 and $183.90. Today it is 7.2% below that high and 16% above its low.
On the business: revenue grew 8.8% year over year; net margin is 14.9%; it trades at 33.6 times earnings.
Its beta is 0.85: it moves roughly in line with the market.
Balchem Corporation is a specialty ingredients and solutions company that develops, manufactures, and distributes performance products for nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial applications.
Want to see everything about Balchem?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About $123.59 per share according to ATLAS (reasonable range: $89.13 to $171.36). With the stock at $170.62, it is 38% above it.
54%: close to a coin flip. In half of the simulated outcomes, BCPC ends the month between $166.03 and $176.90.
Balchem's market capitalization is $5.5B. Its price-to-earnings (P/E) ratio is 33.6: you pay $33.6 for each $1 of yearly earnings.
Yes. BCPC's current dividend yield is 0.56% at today's price ($170.62).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy